Back to results
US 2021/0233636 A1Published application
Pharmaceutical business method for high volume low risk sales with accelerated manufacturing
OwnerDavid Brent Morganinventor
Life of this patent
Estimating the term…
Abstract
A business method for pharmaceutical sales in which additional parties or entities are introduced into the transaction such that simultaneous mass manufacturing and seeking regulatory approvals for the sales of pharmaceutical is feasible. The method promotes the early widespread adoption and use of pharmaceuticals while reducing risk and increasing sales volume through guaranteed advance bulk purchase agreements. The resulting method achieves speed to mass markets heretofore not realized.
Claims4
A computerized software analysis method for high volume low risk pharmaceutical sales with accelerated manufacturing;
- wherein mass pharmaceutical manufacturing and seeking regulatory approval occur in parallel.
Dependencies are inferred from the claim text.